Holen Sie sich die Stockscreener-App
1.8686
3.97%
0.0886
Schlusskurs vom Vortag:
$1.78
Offen:
$1.79
24-Stunden-Volumen:
106.94K
Relative Volume:
0.04
Marktkapitalisierung:
$123.20M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-86.08M
KGV:
-0.8661
EPS:
-2.1574
Netto-Cashflow:
$-72.06M
1W Leistung:
+17.13%
1M Leistung:
-13.92%
6M Leistung:
+105.63%
1J Leistung:
+106.76%
1-Tages-Spanne:
$1.79
$1.87
1-Wochen-Bereich:
$1.56
$1.8588
52-Wochen-Spanne:
$0.66
$2.79
Io Biotech Inc Stock (IOBT) Company Profile
Firmenname
Io Biotech Inc
Sektor
Branche
Telefon
(457) 070-2980
Adresse
OLE MAALOES VEH 3, COPENHAGEN
Vergleichen Sie IOBT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IOBT
Io Biotech Inc
|
1.87 | 117.27M | 0 | -86.08M | -72.06M | -2.1574 |
|
VRTX
Vertex Pharmaceuticals Inc
|
401.93 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
575.00 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.52 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
746.49 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
336.25 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Io Biotech Inc Aktie (IOBT) Neueste Nachrichten
News impact scoring models applied to IO Biotech Inc.July 2025 Big Picture & Growth Focused Stock Reports - Newser
Pattern recognition hints at IO Biotech Inc. upside2025 Top Gainers & Weekly High Return Stock Forecasts - Newser
Will IO Biotech Inc. stock hit new highs in YEARTrade Exit Report & Safe Swing Trade Setups - khodrobank.com
Using Ichimoku Cloud for IO Biotech Inc. technicalsMarket Risk Summary & Capital Efficient Trading Techniques - Newser
IO Biotech’s Strategic Momentum: Evaluating Cylembio’s Pipeline Progress and Investor Engagement as Catalysts for Long-Term Growth - AInvest
IO Biotech Announces Upcoming Investor Conferences and Corporate Update on Cylembio® Development - Quiver Quantitative
IO Biotech to Present at Upcoming Investor Conferences, Highlighting Cylembio Therapeutic Cancer Vaccine Candidate - AInvest
IO Biotech Announces Participation in Upcoming Investor Conferences - The Manila Times
Cancer Vaccine Developer IO Biotech to Present Latest Corporate Updates at Global Healthcare Forums - Stock Titan
Detecting support and resistance levels for IO Biotech Inc.Fed Meeting & Technical Pattern Alert System - Newser
Building trade automation scripts for IO Biotech Inc.Market Volume Summary & Low Risk Entry Point Guides - Newser
How to track smart money flows in IO Biotech Inc.Trade Risk Summary & Daily Technical Forecast Reports - Newser
What are analysts’ price targets for IO Biotech Inc.July 2025 Update & High Conviction Trade Alerts - khodrobank.com
Price momentum metrics for IO Biotech Inc. explained2025 Support & Resistance & Growth Focused Stock Pick Reports - Newser
Volatility clustering patterns for IO Biotech Inc.Market Trend Review & Safe Capital Preservation Plans - Newser
Will IO Biotech Inc. benefit from macro trendsIndex Update & Weekly High Return Stock Forecasts - Newser
Can a trend reversal in IO Biotech Inc. lead to recovery2025 Stock Rankings & AI Enhanced Execution Alerts - Newser
IO Biotech, Inc. (IOBT) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Analyzing recovery setups for IO Biotech Inc. investorsGDP Growth & Safe Capital Growth Plans - Newser
What earnings revisions data tells us about IO Biotech Inc.Quarterly Market Review & Long-Term Growth Portfolio Plans - Newser
Is IO Biotech Inc. stock poised for growthRecession Risk & Verified Entry Point Detection - Newser
Using portfolio simulators with IO Biotech Inc. includedNew Guidance & Free Accurate Trade Setup Notifications - Newser
How liquid is IO Biotech Inc. stockJuly 2025 Technicals & Growth Focused Entry Reports - khodrobank.com
What to do if you’re stuck in IO Biotech Inc.Weekly Profit Summary & Free Weekly Chart Analysis and Trade Guides - Newser
What to expect from IO Biotech Inc. in the next 30 days2025 Top Gainers & Daily Oversold Bounce Ideas - Newser
How to integrate IO Biotech Inc. into portfolio analysis toolsJuly 2025 Breakouts & Verified High Yield Trade Plans - Newser
Can IO Biotech Inc. navigate macro headwindsJuly 2025 Analyst Calls & Long Hold Capital Preservation Plans - khodrobank.com
Does IO Biotech Inc. meet Warren Buffett’s criteria2025 Buyback Activity & Real-Time Volume Surge Alerts - khodrobank.com
Analyzing net buyer seller activity in IO Biotech Inc.July 2025 Market Mood & Verified Technical Trade Signals - Newser
Is IO Biotech Inc. forming bullish engulfing patternsQuarterly Investment Review & Accurate Intraday Trading Signals - khodrobank.com
IO Biotech Inc. stock momentum explainedMarket Trend Review & Smart Allocation Stock Reports - Newser
Should you hold or exit IO Biotech Inc. nowQuarterly Profit Summary & Precise Buy Zone Identification - Newser
Full technical analysis of IO Biotech Inc. stock2025 Big Picture & Scalable Portfolio Growth Ideas - Newser
What data driven models say about IO Biotech Inc.’s futureWeekly Trend Report & Breakout Confirmation Alerts - Newser
Volume Recap: What analysts say about IO Biotech Inc. stockProfit Target & Free Daily Entry Point Trade Alerts - khodrobank.com
Analyzing drawdowns of IO Biotech Inc. with statistical tools2025 Top Gainers & Daily Price Action Insights - Newser
Published on: 2025-09-01 11:29:35 - Newser
Why IO Biotech Inc. stock attracts strong analyst attentionTrade Volume Summary & Weekly Top Gainers Alerts - Newser
Applying sector rotation models to IO Biotech Inc.Portfolio Performance Summary & Short-Term Swing Trade Alerts - Newser
Short interest data insights for IO Biotech Inc.2025 Risk Factors & Safe Capital Allocation Plans - Newser
Smart tools for monitoring IO Biotech Inc.’s price actionJuly 2025 News Drivers & Safe Entry Trade Signal Reports - Newser
Finanzdaten der Io Biotech Inc-Aktie (IOBT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Io Biotech Inc-Aktie (IOBT) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Ahmad Qasim Iftikhar | Chief Medical Officer |
Dec 23 '24 |
Buy |
0.85 |
31,350 |
26,553 |
31,350 |
| Zocca Mai-Britt | Chief Executive Officer |
Dec 23 '24 |
Buy |
0.81 |
12,500 |
10,120 |
49,891 |
| Sullivan Amy | Chief Financial Officer |
Dec 23 '24 |
Buy |
0.83 |
10,250 |
8,483 |
84,632 |
| Smith Devin Whittemore | General Counsel |
Dec 23 '24 |
Buy |
0.81 |
12,000 |
9,720 |
16,938 |
0.23%
0.69%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):